CVS Health stock up 0.43% at EUR 73.13 before Xetra opens
Published on 11/20/2026 at 08:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCVS Health: Key Investor Factors
- RBC Capital Markets lowered its CVS Health price target to USD 108 from USD 113 while keeping an Outperform rating.
- CVS Health serves customers through health benefits, pharmacy benefit management and retail pharmacy operations.
- The planned business separation remains a strategic focus for investors.
CVS Health stock traded at EUR 73.13 on Lang & Schwarz at 08:46 CET on Friday, November 20, 2026, 0.43 percent above the Xetra close of Thursday, November 19, at EUR 72.82.
CVS Health provides medical benefits management, pharmacy benefit management and retail pharmacy services, including prescription medicines, over-the-counter products and clinics.
On November 16, MarketScreener reported that RBC Capital Markets lowered its price target to USD 108 from USD 113 and kept its Outperform rating. The move comes as investors assess the planned separation of CVS Health businesses.
US equities are tracked through the S&P 500.
Disclaimer...
en | US1266501006 | CVS HEALTH CORP. | boerse | 70539163 | bgmi
